Cargando…
Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis‐generating Small Clinical Studies
Easy‐to‐use naloxone formulations are needed to help address the opioid overdose epidemic. The pharmacokinetics of i.v., i.m., and a new i.n. naloxone formulation (2 mg) were compared in six healthy volunteers. Relative to i.m. naloxone, geometric mean (90% confidence interval [CI]) absolute bioavai...
Autores principales: | Gufford, BT, Ainslie, GR, White, JR, Layton, ME, Padowski, JM, Pollack, GM, Paine, MF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593165/ https://www.ncbi.nlm.nih.gov/pubmed/28504483 http://dx.doi.org/10.1111/cts.12473 |
Ejemplares similares
-
Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl
por: Barr, Ciara A., et al.
Publicado: (2023) -
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial
por: Dietze, Paul, et al.
Publicado: (2019) -
Quantitative prediction and clinical evaluation of an unexplored herb–drug interaction mechanism in healthy volunteers
por: Gufford, BT, et al.
Publicado: (2015) -
Intranasal versus Intramuscular/Intravenous Naloxone for Pre-hospital Opioid Overdose: A Systematic Review and Meta-analysis
por: Yousefifard, Mahmoud, et al.
Publicado: (2019) -
A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose
por: Lapidot, Tair, et al.
Publicado: (2022)